Case ReportSecondary rise in blood pressure after renal denervation
References (4)
- et al.
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Lancet
(2009) - et al.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Lancet
(2010)
Cited by (117)
Catheter-based renal artery denervation: facts and expectations
2023, European Journal of Internal MedicineAlcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter
2021, Cardiovascular Revascularization MedicineTranscatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience
2016, JACC: Cardiovascular InterventionsNext generation renal denervation: Chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter
2015, Cardiovascular Revascularization MedicineFrequency of renal artery stenosis after renal denervation in patients with resistant arterial hypertension
2015, American Journal of CardiologyCitation Excerpt :So, next to efficacy, safety remains a key issue in RAD.13,21,22 To the best of our knowledge, no systematic imaging analysis of renal arteries after RAD has been published so far, although the number of single case reports on patients with renal artery stenosis after RAD is increasing.14–18 In our study, we systematically evaluated renal artery morphology in 76 patients after RAD.
Renal denervation for treatment of drug-resistant hypertension
2015, Trends in Cardiovascular MedicineCitation Excerpt :Despite experimental studies with radiofrequency ablation of renal nerves in pigs showing some vascular damage [25], with clinical follow-up now as long as seven years, the long-term safety in patients is good, perhaps exceeding expectations. Despite some endothelial damage during the denervation procedure, sometimes accompanied by microthromboses detected with optical coherence tomography [41], renal artery stenosis at the site of energy delivery from induced renal artery atherosclerosis or perhaps fibrous stricture is very uncommon [42]. This demonstrated vascular safety suggests that in the next round of renal denervation development and testing, higher energy doses should be used, as denervation currently achieved appears to be commonly suboptimal, and a vascular safety margin exists.